Phase I Trial of E7389 (Halichondrin B Analog) (NSC# 707389) in Patients With Advanced Solid Tumors
Phase of Trial: Phase I
Latest Information Update: 22 Oct 2016
At a glance
- Drugs Eribulin (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 29 Oct 2007 Status changed from suspended to in progress.
- 21 Sep 2005 New trial record.